Fresh 13F filing data confirms what many derivatives traders suspected: the initial demand wave behind US spot Solana ETFs was not retail-driven. According to Bloomberg ETF analyst James Seyffart, the 30 largest institutional holders of US-listed spot Solana ETFs accumulated over $540 million in combined positions during Q4 2024 — representing roughly 50% of total assets under management across these products.
For SOL perp traders, this is structurally significant. Institutional accumulation at scale tends to suppress short-term sell pressure in spot markets, which in turn can compress negative funding rates and reduce the frequency of long liquidation cascades — at least while those holders maintain conviction.
Who Were the Largest Holders of US Spot Solana ETFs?
The buyer list reads like a cross-section of institutional crypto exposure. Electric Capital led all holders with a position valued near $138 million. Goldman Sachs followed at $107.4 million, with Elequin Capital, SIG Holding, and Multicoin Capital rounding out the top five. Morgan Stanley and Citadel Advisors also appeared in the filing data — two names that carry considerable weight in terms of signaling broader institutional appetite.
Breaking down the $540 million by entity type: investment advisors led with over $270 million, hedge fund managers contributed $186.4 million, holding companies and brokerages added $60 million and $20 million respectively, while banks accounted for just $4.5 million.
The first US spot Solana ETF — from Bitwise — received SEC approval and began trading on October 28, 2024. Since launch, cumulative net inflows across all US-listed spot Solana ETFs have exceeded $950 million, per Farside Investors data, a figure that encompasses retail and smaller institutional flows not captured in 13F disclosures.
How Does the SOL Price Decline Affect Perpetual Futures Positioning?
The entry point for Q4 institutional buyers is now materially underwater. Those positions were backed by approximately 4.3 million SOL tokens, priced at roughly $124.95 at year-end 2024. As of March 2025, SOL was trading near $86.50 at the time of Seyffart's analysis — a drawdown of more than 30% from those cost basis levels. At the time of writing, SOL/USD is quoted around $87.70.
In perpetual futures markets, a 30% spot decline of this magnitude typically triggers a shift in funding rates toward negative territory as leveraged longs get flushed and speculative shorts build. However, Bloomberg ETF analyst Eric Balchunas noted that net ETF inflows have remained relatively stable despite the token's price deterioration — a signal that the institutional buyer base is not capitulating, which could act as a floor for spot demand and limit the severity of extended negative funding environments on SOL perps.
The persistence of inflows despite drawdown also suggests this cohort is positioned with longer time horizons, reducing the probability of coordinated spot selling that would otherwise accelerate open interest unwinds on derivatives venues.
What's Missing From the Data — and When Will It Update?
The 13F filings cover Q4 2024 only. Updated disclosures for Q1 2025 are not due until mid-May, leaving a critical gap: traders currently have no visibility into whether institutions added to positions, trimmed exposure, or held flat through the 30%+ decline. That uncertainty is itself a market variable — until Q1 data surfaces, any narrative around institutional conviction in SOL remains partially speculative.
Trading Implications
- Institutional holders entered at an average cost basis near
$124.95per SOL — current prices around$87.70represent a~30%drawdown, creating potential overhead resistance if these holders look to exit at breakeven. - Steady ETF inflows despite price weakness suggest spot demand is absorbing sell pressure, which may limit the depth of negative funding rate regimes on SOL perpetual markets in the near term.
- The
50%institutional ownership share reduces the likelihood of panic-driven liquidation cascades typical of retail-dominated assets, but does not eliminate downside risk if macro conditions deteriorate. - Q1 2025 13F filings, due mid-May, will be a critical data release for reassessing institutional conviction and recalibrating directional bias on SOL perps.
- Goldman Sachs and Citadel's presence in the holder list may attract additional institutional flow, potentially supporting open interest growth on regulated SOL derivatives products over the medium term.